Clinical Trial Update: Evaluating the True Magnitude of HYPOglycemic Events After THE Initiation of Sulfonylurea

View source ↗

Summary

Terminated clinical trial update evaluating the magnitude of hypoglycemic events after initiation of a sulfonylurea in Type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Sulfonylurea (class)

Snippet

Sponsor: Institut de Recherches Cliniques de Montreal | Conditions: Type 2 Diabetes | Status: TERMINATED